These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 37119647)

  • 1. Improving fine needle aspiration to predict the tumor biological aggressiveness in pancreatic neuroendocrine tumors using Ki-67 proliferation index, phosphorylated histone H3 (PHH3), and BCL-2.
    Zhao CL; Dabiri B; Hanna I; Lee L; Xiaofei Z; Hossein-Zadeh Z; Cao W; Allendorf J; Rodriguez AP; Weng K; Turunbedu S; Boyd A; Gupta M
    Ann Diagn Pathol; 2023 Aug; 65():152149. PubMed ID: 37119647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of endoscopic ultrasonography and endoscopic ultrasonography-guided fine-needle aspiration for the diagnosis and grading of pancreatic neuroendocrine tumors.
    Fujimori N; Osoegawa T; Lee L; Tachibana Y; Aso A; Kubo H; Kawabe K; Igarashi H; Nakamura K; Oda Y; Ito T
    Scand J Gastroenterol; 2016; 51(2):245-52. PubMed ID: 26513346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of Ki-67 index in EUS-FNA specimens for the assessment of malignancy risk in pancreatic neuroendocrine tumors.
    Hasegawa T; Yamao K; Hijioka S; Bhatia V; Mizuno N; Hara K; Imaoka H; Niwa Y; Tajika M; Kondo S; Tanaka T; Shimizu Y; Kinoshita T; Kohsaki T; Nishimori I; Iwasaki S; Saibara T; Hosoda W; Yatabe Y
    Endoscopy; 2014 Jan; 46(1):32-8. PubMed ID: 24218309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of endoscopic ultrasonography-guided fine needle aspiration for pancreatic neuroendocrine tumor grading.
    Sugimoto M; Takagi T; Hikichi T; Suzuki R; Watanabe K; Nakamura J; Kikuchi H; Konno N; Waragai Y; Asama H; Takasumi M; Watanabe H; Obara K; Ohira H
    World J Gastroenterol; 2015 Jul; 21(26):8118-24. PubMed ID: 26185384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pancreatic neuroendocrine tumors: accurate grading with Ki-67 index on fine-needle aspiration specimens using the WHO 2010/ENETS criteria.
    Farrell JM; Pang JC; Kim GE; Tabatabai ZL
    Cancer Cytopathol; 2014 Oct; 122(10):770-8. PubMed ID: 25044931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The diagnostic value of FNA biopsy in grading pancreatic neuroendocrine tumors.
    Laskiewicz L; Jamshed S; Gong Y; Ainechi S; LaFemina J; Wang X
    Cancer Cytopathol; 2018 Mar; 126(3):170-178. PubMed ID: 29266776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison between EUS-guided fine-needle aspiration cytology and EUS-guided fine-needle biopsy histology for the evaluation of pancreatic neuroendocrine tumors.
    Crinò SF; Ammendola S; Meneghetti A; Bernardoni L; Conti Bellocchi MC; Gabbrielli A; Landoni L; Paiella S; Pin F; Parisi A; Mastrosimini MG; Amodio A; Frulloni L; Facciorusso A; Larghi A; Manfrin E
    Pancreatology; 2021 Mar; 21(2):443-450. PubMed ID: 33390343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accuracy of Pancreatic Neuroendocrine Tumour Grading by Endoscopic Ultrasound-Guided Fine Needle Aspiration: Analysis of a Large Cohort and Perspectives for Improvement.
    Boutsen L; Jouret-Mourin A; Borbath I; van Maanen A; Weynand B
    Neuroendocrinology; 2018; 106(2):158-166. PubMed ID: 28494461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fine-needle aspiration biopsy of pancreatic neuroendocrine tumors: Correlation between Ki-67 index in cytological samples and clinical behavior.
    Díaz Del Arco C; Esteban López-Jamar JM; Ortega Medina L; Díaz Pérez JÁ; Fernández Aceñero MJ
    Diagn Cytopathol; 2017 Jan; 45(1):29-35. PubMed ID: 27863178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accuracy of grading pancreatic neuroendocrine neoplasms with Ki-67 index in fine-needle aspiration cellblock material.
    Grosse C; Noack P; Silye R
    Cytopathology; 2019 Mar; 30(2):187-193. PubMed ID: 30303569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pancreatic neuroendocrine tumour grading on endoscopic ultrasound-guided fine needle aspiration: high reproducibility and inter-observer agreement of the Ki-67 labelling index.
    Weynand B; Borbath I; Bernard V; Sempoux C; Gigot JF; Hubert C; Lannoy V; Deprez PH; Jouret-Mourin A
    Cytopathology; 2014 Dec; 25(6):389-95. PubMed ID: 24750272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Accurate grading of pancreatic neuroendocrine tumors with Ki-67 index in fine-needle aspiration specimens: a comparative cytologic and histologic study].
    He SR; Cui D; Gong H; Zhu YP; Chen L; Hu ST; Liu DG
    Zhonghua Bing Li Xue Za Zhi; 2017 Jun; 46(6):393-399. PubMed ID: 28591986
    [No Abstract]   [Full Text] [Related]  

  • 13. The Impact of Phosphohistone-H3-Assisted Mitotic Count and Ki67 Score in the Determination of Tumor Grade and Prediction of Distant Metastasis in Well-Differentiated Pancreatic Neuroendocrine Tumors.
    Ozturk Sari S; Taskin OC; Gundogdu G; Yegen G; Onder S; Keskin M; Saglam S; Ozluk Y; Gulluoglu M; Mete O
    Endocr Pathol; 2016 Jun; 27(2):162-70. PubMed ID: 26936845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical relevance of performing endoscopic ultrasound-guided fine-needle biopsy for pancreatic neuroendocrine tumors less than 2 cm.
    Heidsma CM; Tsilimigras DI; Rocha F; Abbott DE; Fields R; Smith PM; Poultsides GA; Cho C; van Eijck C; van Dijkum EN; Maithel SK; Pawlik TM;
    J Surg Oncol; 2020 Dec; 122(7):1393-1400. PubMed ID: 32783272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphorylated Histone H3 (PHH3) Is a Superior Proliferation Marker for Prognosis of Pancreatic Neuroendocrine Tumors.
    Villani V; Mahadevan KK; Ligorio M; Fernández-Del Castillo C; Ting DT; Sabbatino F; Zhang I; Vangel M; Ferrone S; Warshaw AL; Lillemoe KD; Wargo J; Deshpande V; Ferrone CR
    Ann Surg Oncol; 2016 Dec; 23(Suppl 5):609-617. PubMed ID: 27020585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The usefulness of endoscopic ultrasound-guided fine-needle aspiration for the diagnosis of pancreatic neuroendocrine tumors based on the World Health Organization classification.
    Unno J; Kanno A; Masamune A; Kasajima A; Fujishima F; Ishida K; Hamada S; Kume K; Kikuta K; Hirota M; Motoi F; Unno M; Shimosegawa T
    Scand J Gastroenterol; 2014 Nov; 49(11):1367-74. PubMed ID: 25180490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reliability of Ki-67 Determination in FNA Samples for Grading Pancreatic Neuroendocrine Tumors.
    Díaz Del Arco C; Díaz Pérez JÁ; Ortega Medina L; Sastre Valera J; Fernández Aceñero MJ
    Endocr Pathol; 2016 Dec; 27(4):276-283. PubMed ID: 27688080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphohistone H3 and Ki-67 labeling indices in cytologic specimens from well-differentiated neuroendocrine tumors of the gastrointestinal tract and pancreas: a comparative analysis using automated image cytometry.
    Fung AD; Cohen C; Kavuri S; Lawson D; Gao X; Reid MD
    Acta Cytol; 2013; 57(5):501-8. PubMed ID: 24021213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cystic pancreatic neuroendocrine tumors: outcomes of preoperative endosonography-guided fine needle aspiration, and recurrence during long-term follow-up.
    Ridtitid W; Halawi H; DeWitt JM; Sherman S; LeBlanc J; McHenry L; Coté GA; Al-Haddad MA
    Endoscopy; 2015 Jul; 47(7):617-25. PubMed ID: 25763832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pancreatic Neuroendocrine Tumours: The Role of Endoscopic Ultrasound Biopsy in Diagnosis and Grading Based on the WHO 2017 Classification.
    Di Leo M; Poliani L; Rahal D; Auriemma F; Anderloni A; Ridolfi C; Spaggiari P; Capretti G; Di Tommaso L; Preatoni P; Zerbi A; Carnaghi C; Lania A; Malesci A; Repici A; Carrara S
    Dig Dis; 2019; 37(4):325-333. PubMed ID: 30897588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.